chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 23.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Rhinorrhoea, SARS-CoV-2 test negative, Sneezing, Streptococcus test negative
Clinical narrative: On 03/19/2023 I went  to the beach it was cold and windy , temperature of 65. After coming back from the beach I had a runny nose and I was sneezing.. It continued till 2  weeks. On 04/01/2023  I started  having a severe cough, runny nose,  muscles ache, shortness of breath and hard to breath. 04/09/2023 I had a appointment at the pharmacy for COVID-19 test  was negative, strep test was negative. They told  me that it was a common cold and prescribed me with a cough medication Brompheniramine- Pseudoephedrine- DM ( 5 days) .  On 04/15/2023 I had runny nose , cough, and muscles aches. On 04/21/2023 I went to get more tests done such at STD and HIV which was negative.  On 04/22/2023 I still have a dry cough,  and muscles aches. On 04/23/2023 I went to the doctor again I was prescribed with inhaler, Antibiotics ( Azithromycin) 6 days   and cough syrup ( Benzonatate). After finishing the medication  my symptoms reduced but it didn't go away completely. I try to use Vicks  but it lost it's effectiveness on me. This is something new that I am experience.  In total I went to the doctors like 3 times.  I will be scheduling another appointment  for the severe cough which I still have . I don't even have fever so no one is sure what is going on with me.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Rash, Transient global amnesia
Clinical narrative: I had a sore arm and achy after receiving the vaccine. On 11/14/2022, I developed a rash on my neck in the center and then it spread. As of today, I still have the rash on my back and legs. I have seen my doctor and my dermatologist, and it is undetermined what it is. I am using a topical cream to help with the symptoms. I also bath and wash my hair in liquid coal. I was hospitalized on 11/09/2022 for transit global amnesia. I spent the night for observation.
Sex: F
Vaccine: HEPA
Symptoms: No adverse event, Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: The 4-day old newborn was scheduled to receive her first dose of the Hepatitis B vaccine. The correct vaccine was ordered, but the medical assistant erroneously administered a Hepatitis A vaccine instead.  The error was noted when the medical assistant was entering the vaccine administration information into the patient's chart. The physician and the CDC Clinical Immunization Safety Assessment (CISA) Project were contacted.  The newborn has been closely monitored and returned for a recheck appointment the following day.  She has been afebrile and continues to feed and act well.  No side effects have been noted.
Age: 85.0
Sex: M
Vaccine: COVID19-2
Symptoms: Asthenia, Blood electrolytes, COVID-19, Cough, Electrolyte substitution therapy
Clinical narrative: Discharge Physician: DO Primary Care Physician: MD  Date of Admission: 3/25/2023 Discharge Date: 3/26/2023 Room Number:   PRESENTING PROBLEM: Acute febrile illness [R50.9] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a n 86 year old male with history of dementia, CKD, chronic hypotension on midodrine, Type 2 DM, HLD, and chronic DVT on warfarin who presented to ED with weakness, fevers, and cough worsening over the previous 2-3 days. In the ED, The patient tested positive for covid, and UA indicated a possible infection, he was also found to have an elevated lactic acid. Due to the patient's profound weakness, the hospitalist team was consulted for admission. The patient was started on IV Rocephin and received IV fluids. During admission, the patient worked with therapy and felt to be doing much better, they felt he was safe for home with assistance and with home health and PT, the family declines this at this time, but will discuss with the patient's PCP. He remained off oxygen, no issues eating or drinking, his wife felt he was at his baseline. He was transitioned to oral antibiotics, cultures are pending and I instructed the wife I will call if there needs to be a change in antibiotics. She was agreeable to the plan and the patient is medically stable for discharge.   During the ED evaluation and admission, the patient was noted to have mild hypoglycemia, even after meals, his glyberide has been discontinued at this time.   Patient has been out of his midodrine, this has been sent to his pharmacy.   Electrolytes were monitored and repleted PRN throughout the admission. Patient clinically improved and hemodynamically stable for discharge.  Discussed plan of care discharge with patient including outpatient follow-up PCP within 7 days. Patient voiced understanding was agreeable with plan of care discharge.
Age: 85.0
Sex: M
Vaccine: COVID19-2
Symptoms: Hypoglycaemia, Product use issue, Pyrexia, SARS-CoV-2 test positive, Urine analysis abnormal
Clinical narrative: Discharge Physician: DO Primary Care Physician: MD  Date of Admission: 3/25/2023 Discharge Date: 3/26/2023 Room Number:   PRESENTING PROBLEM: Acute febrile illness [R50.9] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a n 86 year old male with history of dementia, CKD, chronic hypotension on midodrine, Type 2 DM, HLD, and chronic DVT on warfarin who presented to ED with weakness, fevers, and cough worsening over the previous 2-3 days. In the ED, The patient tested positive for covid, and UA indicated a possible infection, he was also found to have an elevated lactic acid. Due to the patient's profound weakness, the hospitalist team was consulted for admission. The patient was started on IV Rocephin and received IV fluids. During admission, the patient worked with therapy and felt to be doing much better, they felt he was safe for home with assistance and with home health and PT, the family declines this at this time, but will discuss with the patient's PCP. He remained off oxygen, no issues eating or drinking, his wife felt he was at his baseline. He was transitioned to oral antibiotics, cultures are pending and I instructed the wife I will call if there needs to be a change in antibiotics. She was agreeable to the plan and the patient is medically stable for discharge.   During the ED evaluation and admission, the patient was noted to have mild hypoglycemia, even after meals, his glyberide has been discontinued at this time.   Patient has been out of his midodrine, this has been sent to his pharmacy.   Electrolytes were monitored and repleted PRN throughout the admission. Patient clinically improved and hemodynamically stable for discharge.  Discussed plan of care discharge with patient including outpatient follow-up PCP within 7 days. Patient voiced understanding was agreeable with plan of care discharge.
Age: 85.0
Sex: M
Vaccine: COVID19-2
Symptoms: Urine lactic acid increased
Clinical narrative: Discharge Physician: DO Primary Care Physician: MD  Date of Admission: 3/25/2023 Discharge Date: 3/26/2023 Room Number:   PRESENTING PROBLEM: Acute febrile illness [R50.9] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a n 86 year old male with history of dementia, CKD, chronic hypotension on midodrine, Type 2 DM, HLD, and chronic DVT on warfarin who presented to ED with weakness, fevers, and cough worsening over the previous 2-3 days. In the ED, The patient tested positive for covid, and UA indicated a possible infection, he was also found to have an elevated lactic acid. Due to the patient's profound weakness, the hospitalist team was consulted for admission. The patient was started on IV Rocephin and received IV fluids. During admission, the patient worked with therapy and felt to be doing much better, they felt he was safe for home with assistance and with home health and PT, the family declines this at this time, but will discuss with the patient's PCP. He remained off oxygen, no issues eating or drinking, his wife felt he was at his baseline. He was transitioned to oral antibiotics, cultures are pending and I instructed the wife I will call if there needs to be a change in antibiotics. She was agreeable to the plan and the patient is medically stable for discharge.   During the ED evaluation and admission, the patient was noted to have mild hypoglycemia, even after meals, his glyberide has been discontinued at this time.   Patient has been out of his midodrine, this has been sent to his pharmacy.   Electrolytes were monitored and repleted PRN throughout the admission. Patient clinically improved and hemodynamically stable for discharge.  Discussed plan of care discharge with patient including outpatient follow-up PCP within 7 days. Patient voiced understanding was agreeable with plan of care discharge.
Age: 48.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acoustic stimulation tests, Blood test, Borrelia test, Dizziness, Ear discomfort
Clinical narrative: I received the PFIZER Updated Booster Bivalent GLO446 on 2/18/2023 which is what I put in Item 4.  Your system would not allow me to select this option saying it was not available before 8/31/22.  I think you have a glitch.  Within 10 days of receiving the Pfizer Bivalent booster I had a sudden onset on ringing in my ears, intense pain in my right ear and constant pressure in my left ear, and dizziness.  I have been to my PCP, audiologist, chiropractor and am waiting to see an ENT.  I have been diagnosed with tinnitus. I have had an MRI of my head and am waiting for an mri of my upper cervical spine.
Age: 48.0
Sex: F
Vaccine: COVID19-2
Symptoms: Ear pain, Inflammatory marker test, Magnetic resonance imaging head, Otoacoustic emissions test, Spinal X-ray
Clinical narrative: I received the PFIZER Updated Booster Bivalent GLO446 on 2/18/2023 which is what I put in Item 4.  Your system would not allow me to select this option saying it was not available before 8/31/22.  I think you have a glitch.  Within 10 days of receiving the Pfizer Bivalent booster I had a sudden onset on ringing in my ears, intense pain in my right ear and constant pressure in my left ear, and dizziness.  I have been to my PCP, audiologist, chiropractor and am waiting to see an ENT.  I have been diagnosed with tinnitus. I have had an MRI of my head and am waiting for an mri of my upper cervical spine.
Age: 48.0
Sex: F
Vaccine: COVID19-2
Symptoms: Tinnitus
Clinical narrative: I received the PFIZER Updated Booster Bivalent GLO446 on 2/18/2023 which is what I put in Item 4.  Your system would not allow me to select this option saying it was not available before 8/31/22.  I think you have a glitch.  Within 10 days of receiving the Pfizer Bivalent booster I had a sudden onset on ringing in my ears, intense pain in my right ear and constant pressure in my left ear, and dizziness.  I have been to my PCP, audiologist, chiropractor and am waiting to see an ENT.  I have been diagnosed with tinnitus. I have had an MRI of my head and am waiting for an mri of my upper cervical spine.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension
Clinical narrative: I went in for a routine health exam they noticed my blood pressure was high at the beginning of the exam. They said they would check it again before I left to see if it would come down any. By the end of my exam, I was relaxed and did not feel stressed, my blood pressure was still high. I was diagnosed with hypertension and started on Amlodipine. I went back in on May 3, 2023, for a follow up exam. My doctor feels the strength is not bringing my blood pressure down enough and has increased my dose that I will start once I pick the medication up at the pharmacy.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Anaemia, Hypotension, Melaena, Septic shock
Clinical narrative: vaccine was administered - reported by patient ? NO LOT NUMBER WERE SUPPLIED ---------------------------------------------------------------------------------------------------------------------- HYPOTENSION 4/13/2022 MELENA HYPOTENSION 4/13/2022 ANEMIA SEPTIC SHOCK
Age: 0.25
Sex: F
Vaccine: RV5
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient was 15 weeks and 6 days at the time of administration, and the vaccine is not indicated for the first dose past 15 weeks of age.
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: None reported
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Aortic aneurysm, Hyponatraemia
Clinical narrative: J96.00 ACUTE RESPIRATORY FAILURE 8/8/2021 ABDOMINAL AORTIC ANEURYSM, UNSPECIFIED PART J96.00 ACUTE RESPIRATORY FAILURE 8/8/2021 HYPONATREMIA
Age: 0.17
Sex: M
Vaccine: DTPPVHBHPB, PNC13, RV5, DTPPVHBHPB, PNC13, RV5
Symptoms: Dermatitis, Rash
Clinical narrative: Patient recevied vasccines on 5/1/2023 returned on 5/2/2023 with rash on body for 1 day. Dr. assessed the patient and stated Dermatitis VS reaction to vaccines. He presccribed Hydrocortisone !% to apply BID. On 5/5/2023 I called paretn and she stated that rash is less.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia, Hypoxic-ischaemic encephalopathy, Septic shock
Clinical narrative: R09.02 HYPOXIA 4/20/2021 ANOXIC ENCEPHALOPATHY R09.02 HYPOXIA 4/20/2021 SEPTIC SHOCK
Age: 43.0
Sex: M
Vaccine: COVID19-2
Symptoms: Abdominal X-ray, Anion gap increased, Blood glucose increased, Blood prolactin normal, Blood sodium increased
Clinical narrative: I was having the symptoms of all of my chronic conditions. On 11/4/2022, I reported an increased cough to my doctor, though no new medications were prescribed. The doctor just recommended that I use more albuterol. On 11/15/2022, I went back to the doctor, because my cough was still bad, and I demanded that something be done. However, no new treatments were offered. On 2/7/2023, I returned to the same doctor with similar complaints of increased cough. I was then prescribed azithromycin and TESSALON for cough. This was to be taken to addition to the albuterol HFA, which the doctor had already prescribed. On 2/9/2023 and 2/23/2023, wheezing was reported. On this occasion, oral prednisone was prescribed. On 2/23/2023, I returned to the same doctor for a follow-up after antibiotic treatments for my cough and wheezing. Additional treatment was an ANORO ELLIPTA inhaler and, additionally, fluticasone propionate nasal spray. On 3/28/2023, I returned to the same doctor for a follow-up regarding the cough and wheezing. The doctor recommended continuing the ANORO ELLIPTA indefinitely until the cough and wheezing improves. On 4/12/2023, I returned to the same doctor with a new complaint of an increased cough. No new medications were prescribed. I was advised to continue taking the ANORO ELLIPTA and the albuterol HFA. On 4/26/2023, I went to express with a complaint of fever, in addition to increased cough. The temperature was up to 101.7. I was self-medicating with TYLENOL and aspirin. The doctor prescribed antibiotics for the fever. He also enhanced my albuterol HFA by prescribing me a chamber. On 5/4/2023, I returned to the doctor for an office visit with a follow-up for increased cough. The plan is to continue using the medications that were already prescribed and to then return in two months for a follow-up.
Age: 43.0
Sex: M
Vaccine: COVID19-2
Symptoms: Blood testosterone decreased, Blood triglycerides increased, Chest X-ray abnormal, Chest X-ray normal, Condition aggravated
Clinical narrative: I was having the symptoms of all of my chronic conditions. On 11/4/2022, I reported an increased cough to my doctor, though no new medications were prescribed. The doctor just recommended that I use more albuterol. On 11/15/2022, I went back to the doctor, because my cough was still bad, and I demanded that something be done. However, no new treatments were offered. On 2/7/2023, I returned to the same doctor with similar complaints of increased cough. I was then prescribed azithromycin and TESSALON for cough. This was to be taken to addition to the albuterol HFA, which the doctor had already prescribed. On 2/9/2023 and 2/23/2023, wheezing was reported. On this occasion, oral prednisone was prescribed. On 2/23/2023, I returned to the same doctor for a follow-up after antibiotic treatments for my cough and wheezing. Additional treatment was an ANORO ELLIPTA inhaler and, additionally, fluticasone propionate nasal spray. On 3/28/2023, I returned to the same doctor for a follow-up regarding the cough and wheezing. The doctor recommended continuing the ANORO ELLIPTA indefinitely until the cough and wheezing improves. On 4/12/2023, I returned to the same doctor with a new complaint of an increased cough. No new medications were prescribed. I was advised to continue taking the ANORO ELLIPTA and the albuterol HFA. On 4/26/2023, I went to express with a complaint of fever, in addition to increased cough. The temperature was up to 101.7. I was self-medicating with TYLENOL and aspirin. The doctor prescribed antibiotics for the fever. He also enhanced my albuterol HFA by prescribing me a chamber. On 5/4/2023, I returned to the doctor for an office visit with a follow-up for increased cough. The plan is to continue using the medications that were already prescribed and to then return in two months for a follow-up.
Age: 43.0
Sex: M
Vaccine: COVID19-2
Symptoms: Cough, Echocardiogram, Echocardiogram abnormal, Flatulence, Glycosylated haemoglobin increased
Clinical narrative: I was having the symptoms of all of my chronic conditions. On 11/4/2022, I reported an increased cough to my doctor, though no new medications were prescribed. The doctor just recommended that I use more albuterol. On 11/15/2022, I went back to the doctor, because my cough was still bad, and I demanded that something be done. However, no new treatments were offered. On 2/7/2023, I returned to the same doctor with similar complaints of increased cough. I was then prescribed azithromycin and TESSALON for cough. This was to be taken to addition to the albuterol HFA, which the doctor had already prescribed. On 2/9/2023 and 2/23/2023, wheezing was reported. On this occasion, oral prednisone was prescribed. On 2/23/2023, I returned to the same doctor for a follow-up after antibiotic treatments for my cough and wheezing. Additional treatment was an ANORO ELLIPTA inhaler and, additionally, fluticasone propionate nasal spray. On 3/28/2023, I returned to the same doctor for a follow-up regarding the cough and wheezing. The doctor recommended continuing the ANORO ELLIPTA indefinitely until the cough and wheezing improves. On 4/12/2023, I returned to the same doctor with a new complaint of an increased cough. No new medications were prescribed. I was advised to continue taking the ANORO ELLIPTA and the albuterol HFA. On 4/26/2023, I went to express with a complaint of fever, in addition to increased cough. The temperature was up to 101.7. I was self-medicating with TYLENOL and aspirin. The doctor prescribed antibiotics for the fever. He also enhanced my albuterol HFA by prescribing me a chamber. On 5/4/2023, I returned to the doctor for an office visit with a follow-up for increased cough. The plan is to continue using the medications that were already prescribed and to then return in two months for a follow-up.
Age: 43.0
Sex: M
Vaccine: COVID19-2
Symptoms: Gram stain, Gram stain positive, High density lipoprotein decreased, Lipids abnormal, Metabolic function test abnormal
Clinical narrative: I was having the symptoms of all of my chronic conditions. On 11/4/2022, I reported an increased cough to my doctor, though no new medications were prescribed. The doctor just recommended that I use more albuterol. On 11/15/2022, I went back to the doctor, because my cough was still bad, and I demanded that something be done. However, no new treatments were offered. On 2/7/2023, I returned to the same doctor with similar complaints of increased cough. I was then prescribed azithromycin and TESSALON for cough. This was to be taken to addition to the albuterol HFA, which the doctor had already prescribed. On 2/9/2023 and 2/23/2023, wheezing was reported. On this occasion, oral prednisone was prescribed. On 2/23/2023, I returned to the same doctor for a follow-up after antibiotic treatments for my cough and wheezing. Additional treatment was an ANORO ELLIPTA inhaler and, additionally, fluticasone propionate nasal spray. On 3/28/2023, I returned to the same doctor for a follow-up regarding the cough and wheezing. The doctor recommended continuing the ANORO ELLIPTA indefinitely until the cough and wheezing improves. On 4/12/2023, I returned to the same doctor with a new complaint of an increased cough. No new medications were prescribed. I was advised to continue taking the ANORO ELLIPTA and the albuterol HFA. On 4/26/2023, I went to express with a complaint of fever, in addition to increased cough. The temperature was up to 101.7. I was self-medicating with TYLENOL and aspirin. The doctor prescribed antibiotics for the fever. He also enhanced my albuterol HFA by prescribing me a chamber. On 5/4/2023, I returned to the doctor for an office visit with a follow-up for increased cough. The plan is to continue using the medications that were already prescribed and to then return in two months for a follow-up.
Age: 43.0
Sex: M
Vaccine: COVID19-2
Symptoms: Pyrexia, Tricuspid valve incompetence, Wheezing, White blood cell count decreased
Clinical narrative: I was having the symptoms of all of my chronic conditions. On 11/4/2022, I reported an increased cough to my doctor, though no new medications were prescribed. The doctor just recommended that I use more albuterol. On 11/15/2022, I went back to the doctor, because my cough was still bad, and I demanded that something be done. However, no new treatments were offered. On 2/7/2023, I returned to the same doctor with similar complaints of increased cough. I was then prescribed azithromycin and TESSALON for cough. This was to be taken to addition to the albuterol HFA, which the doctor had already prescribed. On 2/9/2023 and 2/23/2023, wheezing was reported. On this occasion, oral prednisone was prescribed. On 2/23/2023, I returned to the same doctor for a follow-up after antibiotic treatments for my cough and wheezing. Additional treatment was an ANORO ELLIPTA inhaler and, additionally, fluticasone propionate nasal spray. On 3/28/2023, I returned to the same doctor for a follow-up regarding the cough and wheezing. The doctor recommended continuing the ANORO ELLIPTA indefinitely until the cough and wheezing improves. On 4/12/2023, I returned to the same doctor with a new complaint of an increased cough. No new medications were prescribed. I was advised to continue taking the ANORO ELLIPTA and the albuterol HFA. On 4/26/2023, I went to express with a complaint of fever, in addition to increased cough. The temperature was up to 101.7. I was self-medicating with TYLENOL and aspirin. The doctor prescribed antibiotics for the fever. He also enhanced my albuterol HFA by prescribing me a chamber. On 5/4/2023, I returned to the doctor for an office visit with a follow-up for increased cough. The plan is to continue using the medications that were already prescribed and to then return in two months for a follow-up.
Age: 1.83
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Wrong product administered
Clinical narrative: No adverse reactions reported. Incorrect vaccine given due to similar looking vials.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest pain, SARS-CoV-2 test positive
Clinical narrative: 02/21/23 presents to EC ED for "chest pain". PMHx of "hypertrophic cardiomyopathy" "depression"
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Acute respiratory failure, Cerebrovascular accident, Lacunar stroke
Clinical narrative: vaccine was administered - reported by patient ? NO LOT NUMBER WERE SUPPLIED ------------------------------------------------------------------------------------------------------------------------------- ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY 7/12/2021 ABDOMINAL PAIN ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY 7/12/2021 ABDOMINAL PAIN ACUTE RESPIRATORY FAILURE 8/11/2021 ABDOMINAL PAIN ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY 7/12/2021 ACUTE RESPIRATORY FAILURE ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY 7/12/2021 ACUTE RESPIRATORY FAILURE ACUTE RESPIRATORY FAILURE 8/11/2021 ACUTE RESPIRATORY FAILURE
Age: 3.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Vaccination error
Clinical narrative: THERE IS NO ADVERSE EVENT BUT THIS IS CONSIDERED A VACCINE ADMINISTRATION ERROR DUE TO THE LACK OF INFORMATION GIVEN TO US WHEN THE DOSING CHANGED WITH THE REMOVAL OF THE MONOVALENT VACCINE. WE DID NOT RECEIVE ANY UPDATED DOSING INSTRUCTIONS UNTIL THIS WEEK WHICH DID NOT GIVE CLEAR OR APPARENT DIRECTIONS INVOLVING CHANGE IN VIALS AND AGE INDICATIONS. THERE SHOULD HAVE BEEN A COMPLETE HALT IN VACCINATING UNTIL CLEAR AND CONCISE INSTRUCTIONS WERE MADE AVAILABLE TO THE HEALTHCARE INDUSTRY. CLEAR AND CONCISE DOES NOT MEAN SIFTING THROUGH 72 PAGES AND CLICKING ON MULTIPLE LINKS TO FIND THE NEEDLE IN THE HAYSTACK.  NOW WE HAVE A VACCINATION ERROR DUE TO THE LACK OF INFORMATION FROM THOSE IN CHARGE WHO DROPPED THE BALL. WE TAKE NO FAULT IN THIS ERROR. THIS PATIENT SHOULD HAVE RECEIVED THE BLUE CAP GRAY LABEL BIVALENT BUT RECEIVED THE YELLOW LABEL PINK TOP BIVALENT. (WHO USES THESE DESCRIPTIONS TO CLEARLY INSTRUCT PEOPLE ON WHAT TO DO?) THIS IS UNSAFE AND UNCLEAR. YOU ALSO ASSUME THAT WE HAVE KNOWLEDGE OF ALL THE VIALS AND DIFFERENT FORMULATIONS OUT THERE WHEN WE DON'T. YOU TOTALLY DROPPED THE BALL AND THIS ERROR RESTS ON THOSE WHO MAKE THE RULES AND INSTRUCTIONS.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Neuropathy peripheral, Obstructive sleep apnoea syndrome
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  OBSTRUCTIVE SLEEP APNEA NEUROPATHY
Age: 64.0
Sex: M
Vaccine: COVID19-2
Symptoms: Hip surgery, Positron emission tomogram abnormal, Renal cancer, Surgery, X-ray abnormal
Clinical narrative: After receiving the 6th dose I was diagnosed with Clear Cell Kidney Cancer again on 04/25/2023. On 10/21/2022 for the first time I was diagnosed with this cancer and I had 2 surgeries as well. After the 6th dose the doctor informed me that the cancer had returned. They did PET-SCAN and X-RAY where it was revealed with cancer. I had a surgery for my hip on 05/01/2023 I am recovering from it now. I have more appointments coming soon. I am still under treatments as of now and I haven't recovered yet.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia, Symptom recurrence
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE HYPOXIA 10/26/2022 &  01/5/2023 -- RECURRENCE OF SAME SYMPTOMS
Age: 67.0
Sex: M
Vaccine: PPV
Symptoms: Diarrhoea, Fatigue, Pyrexia, Vomiting
Clinical narrative: vaccine 23-03-2023 pm  fever (38.9 celsius) start 24-03-2023pm, end 26-03-2023 diarrhea start 25-03-2023, end 29-03-2023 vomit start 26-03-2023, end 27-03-2023 Fatigue start 24-03-2023, end 04-04-2023  Treatment : patient tried probiotics and consulted clinic the 28-03-2023 ( they took their vitals and suggested rest)
Age: 102.0
Sex: M
Vaccine: COVID19-2
Symptoms: Unevaluable event
Clinical narrative: patient hospitalized
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Acute coronary syndrome, Acute kidney injury, COVID-19, Catheterisation cardiac, Cellulitis
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: MD   Admission Date: 3/26/2023  PRESENTING PROBLEM: Septic shock (HCC) [A41.9, R65.21] Cellulitis [L03.90]    HOSPITAL COURSE:   Per ICU Course: " Patient is a 63 y.o. male with a past medical history of HIV (undectible RNA >1year), DM2, PAD w/ SFA stent (>1year ago in Munson), CABG and PCI (2013 and 2020 respectively), and dHF. He has had 2 recent admission in March 2023 where he went R+L heart cath and echo for chest pain, ultimately treated medically. Found to have cellulitis treated with 4 weeks linezolid. He comes from ED due to shock mostly hypovolemic and septic source so far suspected b/l LE.   Patient reports coming to emergency department 3/26 due to feeling "off".  He says he has had continued pain and drainage of his lower extremities that is not significantly worse.  Denies any other sources of infection (denies diarrhea, chest pain, palpitations, nausea vomiting, fevers, abdominal pain, cough, sputum production, shortness of breath, extremity swelling and pain).  Examination quickly found he was hypotensive requiring pressors with obvious open leg wounds (pictures charted).  He was given 2.5L of fluid resuscitation and was able to be weaned off pressor the following day while on the broad antibiotic coverage.  This also resolved his AKI and lactic acidosis. ID and wound/vascular are following.   Incidentally, patient was found to be COVID positive on 03/26.  He was started on remdesivir and steroids.   On 03/27 afternoon patient experienced severe chest pain.  Given his rising troponins, Cardiology was consulted for re-evaluation.  It was suspected that he had an ACS event of his circumflex artery.  He briefly had hypotension otherwise remained stable.  He was recommended 48 hours of heparin (stop date would be 3/30 8am).  The following night into this morning he has remained relatively asymptomatic and close to baseline.  He did have a slight increase in oxygen requirement following this event that has come down to 3 L NC. Workup during ACS event revealed some mild pulmonary edema. One dose of diuresis was given the only given his tenuous baseline with recent hypovolemic shock.  He otherwise was stable for transfer to floors for further management as mentioned in "recommendations at transfer" below."   Post ICU Course: - He was doing well. He suddenly had v.fib and collapsed while nursing in room. He was DNR/DNI. So chest compression or defibrillation was not done. He passed away on 3/29/2023 1711.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Condition aggravated, Death, Discharge, Diuretic therapy
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: MD   Admission Date: 3/26/2023  PRESENTING PROBLEM: Septic shock (HCC) [A41.9, R65.21] Cellulitis [L03.90]    HOSPITAL COURSE:   Per ICU Course: " Patient is a 63 y.o. male with a past medical history of HIV (undectible RNA >1year), DM2, PAD w/ SFA stent (>1year ago in Munson), CABG and PCI (2013 and 2020 respectively), and dHF. He has had 2 recent admission in March 2023 where he went R+L heart cath and echo for chest pain, ultimately treated medically. Found to have cellulitis treated with 4 weeks linezolid. He comes from ED due to shock mostly hypovolemic and septic source so far suspected b/l LE.   Patient reports coming to emergency department 3/26 due to feeling "off".  He says he has had continued pain and drainage of his lower extremities that is not significantly worse.  Denies any other sources of infection (denies diarrhea, chest pain, palpitations, nausea vomiting, fevers, abdominal pain, cough, sputum production, shortness of breath, extremity swelling and pain).  Examination quickly found he was hypotensive requiring pressors with obvious open leg wounds (pictures charted).  He was given 2.5L of fluid resuscitation and was able to be weaned off pressor the following day while on the broad antibiotic coverage.  This also resolved his AKI and lactic acidosis. ID and wound/vascular are following.   Incidentally, patient was found to be COVID positive on 03/26.  He was started on remdesivir and steroids.   On 03/27 afternoon patient experienced severe chest pain.  Given his rising troponins, Cardiology was consulted for re-evaluation.  It was suspected that he had an ACS event of his circumflex artery.  He briefly had hypotension otherwise remained stable.  He was recommended 48 hours of heparin (stop date would be 3/30 8am).  The following night into this morning he has remained relatively asymptomatic and close to baseline.  He did have a slight increase in oxygen requirement following this event that has come down to 3 L NC. Workup during ACS event revealed some mild pulmonary edema. One dose of diuresis was given the only given his tenuous baseline with recent hypovolemic shock.  He otherwise was stable for transfer to floors for further management as mentioned in "recommendations at transfer" below."   Post ICU Course: - He was doing well. He suddenly had v.fib and collapsed while nursing in room. He was DNR/DNI. So chest compression or defibrillation was not done. He passed away on 3/29/2023 1711.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Echocardiogram, Feeling abnormal, Hypotension, Hypovolaemic shock, Intensive care
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: MD   Admission Date: 3/26/2023  PRESENTING PROBLEM: Septic shock (HCC) [A41.9, R65.21] Cellulitis [L03.90]    HOSPITAL COURSE:   Per ICU Course: " Patient is a 63 y.o. male with a past medical history of HIV (undectible RNA >1year), DM2, PAD w/ SFA stent (>1year ago in Munson), CABG and PCI (2013 and 2020 respectively), and dHF. He has had 2 recent admission in March 2023 where he went R+L heart cath and echo for chest pain, ultimately treated medically. Found to have cellulitis treated with 4 weeks linezolid. He comes from ED due to shock mostly hypovolemic and septic source so far suspected b/l LE.   Patient reports coming to emergency department 3/26 due to feeling "off".  He says he has had continued pain and drainage of his lower extremities that is not significantly worse.  Denies any other sources of infection (denies diarrhea, chest pain, palpitations, nausea vomiting, fevers, abdominal pain, cough, sputum production, shortness of breath, extremity swelling and pain).  Examination quickly found he was hypotensive requiring pressors with obvious open leg wounds (pictures charted).  He was given 2.5L of fluid resuscitation and was able to be weaned off pressor the following day while on the broad antibiotic coverage.  This also resolved his AKI and lactic acidosis. ID and wound/vascular are following.   Incidentally, patient was found to be COVID positive on 03/26.  He was started on remdesivir and steroids.   On 03/27 afternoon patient experienced severe chest pain.  Given his rising troponins, Cardiology was consulted for re-evaluation.  It was suspected that he had an ACS event of his circumflex artery.  He briefly had hypotension otherwise remained stable.  He was recommended 48 hours of heparin (stop date would be 3/30 8am).  The following night into this morning he has remained relatively asymptomatic and close to baseline.  He did have a slight increase in oxygen requirement following this event that has come down to 3 L NC. Workup during ACS event revealed some mild pulmonary edema. One dose of diuresis was given the only given his tenuous baseline with recent hypovolemic shock.  He otherwise was stable for transfer to floors for further management as mentioned in "recommendations at transfer" below."   Post ICU Course: - He was doing well. He suddenly had v.fib and collapsed while nursing in room. He was DNR/DNI. So chest compression or defibrillation was not done. He passed away on 3/29/2023 1711.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Laboratory test abnormal, Lactic acidosis, Limb injury, Pain in extremity, Pulmonary oedema
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: MD   Admission Date: 3/26/2023  PRESENTING PROBLEM: Septic shock (HCC) [A41.9, R65.21] Cellulitis [L03.90]    HOSPITAL COURSE:   Per ICU Course: " Patient is a 63 y.o. male with a past medical history of HIV (undectible RNA >1year), DM2, PAD w/ SFA stent (>1year ago in Munson), CABG and PCI (2013 and 2020 respectively), and dHF. He has had 2 recent admission in March 2023 where he went R+L heart cath and echo for chest pain, ultimately treated medically. Found to have cellulitis treated with 4 weeks linezolid. He comes from ED due to shock mostly hypovolemic and septic source so far suspected b/l LE.   Patient reports coming to emergency department 3/26 due to feeling "off".  He says he has had continued pain and drainage of his lower extremities that is not significantly worse.  Denies any other sources of infection (denies diarrhea, chest pain, palpitations, nausea vomiting, fevers, abdominal pain, cough, sputum production, shortness of breath, extremity swelling and pain).  Examination quickly found he was hypotensive requiring pressors with obvious open leg wounds (pictures charted).  He was given 2.5L of fluid resuscitation and was able to be weaned off pressor the following day while on the broad antibiotic coverage.  This also resolved his AKI and lactic acidosis. ID and wound/vascular are following.   Incidentally, patient was found to be COVID positive on 03/26.  He was started on remdesivir and steroids.   On 03/27 afternoon patient experienced severe chest pain.  Given his rising troponins, Cardiology was consulted for re-evaluation.  It was suspected that he had an ACS event of his circumflex artery.  He briefly had hypotension otherwise remained stable.  He was recommended 48 hours of heparin (stop date would be 3/30 8am).  The following night into this morning he has remained relatively asymptomatic and close to baseline.  He did have a slight increase in oxygen requirement following this event that has come down to 3 L NC. Workup during ACS event revealed some mild pulmonary edema. One dose of diuresis was given the only given his tenuous baseline with recent hypovolemic shock.  He otherwise was stable for transfer to floors for further management as mentioned in "recommendations at transfer" below."   Post ICU Course: - He was doing well. He suddenly had v.fib and collapsed while nursing in room. He was DNR/DNI. So chest compression or defibrillation was not done. He passed away on 3/29/2023 1711.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Septic shock, Shock, Syncope, Troponin increased
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: MD   Admission Date: 3/26/2023  PRESENTING PROBLEM: Septic shock (HCC) [A41.9, R65.21] Cellulitis [L03.90]    HOSPITAL COURSE:   Per ICU Course: " Patient is a 63 y.o. male with a past medical history of HIV (undectible RNA >1year), DM2, PAD w/ SFA stent (>1year ago in Munson), CABG and PCI (2013 and 2020 respectively), and dHF. He has had 2 recent admission in March 2023 where he went R+L heart cath and echo for chest pain, ultimately treated medically. Found to have cellulitis treated with 4 weeks linezolid. He comes from ED due to shock mostly hypovolemic and septic source so far suspected b/l LE.   Patient reports coming to emergency department 3/26 due to feeling "off".  He says he has had continued pain and drainage of his lower extremities that is not significantly worse.  Denies any other sources of infection (denies diarrhea, chest pain, palpitations, nausea vomiting, fevers, abdominal pain, cough, sputum production, shortness of breath, extremity swelling and pain).  Examination quickly found he was hypotensive requiring pressors with obvious open leg wounds (pictures charted).  He was given 2.5L of fluid resuscitation and was able to be weaned off pressor the following day while on the broad antibiotic coverage.  This also resolved his AKI and lactic acidosis. ID and wound/vascular are following.   Incidentally, patient was found to be COVID positive on 03/26.  He was started on remdesivir and steroids.   On 03/27 afternoon patient experienced severe chest pain.  Given his rising troponins, Cardiology was consulted for re-evaluation.  It was suspected that he had an ACS event of his circumflex artery.  He briefly had hypotension otherwise remained stable.  He was recommended 48 hours of heparin (stop date would be 3/30 8am).  The following night into this morning he has remained relatively asymptomatic and close to baseline.  He did have a slight increase in oxygen requirement following this event that has come down to 3 L NC. Workup during ACS event revealed some mild pulmonary edema. One dose of diuresis was given the only given his tenuous baseline with recent hypovolemic shock.  He otherwise was stable for transfer to floors for further management as mentioned in "recommendations at transfer" below."   Post ICU Course: - He was doing well. He suddenly had v.fib and collapsed while nursing in room. He was DNR/DNI. So chest compression or defibrillation was not done. He passed away on 3/29/2023 1711.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Ventricular fibrillation, Wound
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: MD   Admission Date: 3/26/2023  PRESENTING PROBLEM: Septic shock (HCC) [A41.9, R65.21] Cellulitis [L03.90]    HOSPITAL COURSE:   Per ICU Course: " Patient is a 63 y.o. male with a past medical history of HIV (undectible RNA >1year), DM2, PAD w/ SFA stent (>1year ago in Munson), CABG and PCI (2013 and 2020 respectively), and dHF. He has had 2 recent admission in March 2023 where he went R+L heart cath and echo for chest pain, ultimately treated medically. Found to have cellulitis treated with 4 weeks linezolid. He comes from ED due to shock mostly hypovolemic and septic source so far suspected b/l LE.   Patient reports coming to emergency department 3/26 due to feeling "off".  He says he has had continued pain and drainage of his lower extremities that is not significantly worse.  Denies any other sources of infection (denies diarrhea, chest pain, palpitations, nausea vomiting, fevers, abdominal pain, cough, sputum production, shortness of breath, extremity swelling and pain).  Examination quickly found he was hypotensive requiring pressors with obvious open leg wounds (pictures charted).  He was given 2.5L of fluid resuscitation and was able to be weaned off pressor the following day while on the broad antibiotic coverage.  This also resolved his AKI and lactic acidosis. ID and wound/vascular are following.   Incidentally, patient was found to be COVID positive on 03/26.  He was started on remdesivir and steroids.   On 03/27 afternoon patient experienced severe chest pain.  Given his rising troponins, Cardiology was consulted for re-evaluation.  It was suspected that he had an ACS event of his circumflex artery.  He briefly had hypotension otherwise remained stable.  He was recommended 48 hours of heparin (stop date would be 3/30 8am).  The following night into this morning he has remained relatively asymptomatic and close to baseline.  He did have a slight increase in oxygen requirement following this event that has come down to 3 L NC. Workup during ACS event revealed some mild pulmonary edema. One dose of diuresis was given the only given his tenuous baseline with recent hypovolemic shock.  He otherwise was stable for transfer to floors for further management as mentioned in "recommendations at transfer" below."   Post ICU Course: - He was doing well. He suddenly had v.fib and collapsed while nursing in room. He was DNR/DNI. So chest compression or defibrillation was not done. He passed away on 3/29/2023 1711.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: 02/22/23 presents to EC ED for "shortness of breath". PMHx of "asthma, skin CA, HTN, HLD"
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Obstructive sleep apnoea syndrome, Respiratory failure, Symptom recurrence
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE OBSTRUCTIVE SLEEP APNEA ACUTE RESPIRATORY FAILURE ACUTE HYPERCAPNIC RESPIRATORY FAILURE HYPOXEMIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY HYPERCAPNIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 7/31/2022 -- RECURRENCE OF SAME SYMPTOMS
Age: 3.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event, Vaccination error
Clinical narrative: THERE IS NO ADVERSE EVENT BUT THIS IS CONSIDERED A VACCINE ADMINISTRATION ERROR DUE TO THE LACK OF INFORMATION GIVEN TO US WHEN THE DOSING CHANGED WITH THE REMOVAL OF THE MONOVALENT VACCINE. WE DID NOT RECEIVE ANY UPDATED DOSING INSTRUCTIONS UNTIL THIS WEEK WHICH DID NOT GIVE CLEAR OR APPARENT DIRECTIONS INVOLVING CHANGE IN VIALS AND AGE INDICATIONS. THERE SHOULD HAVE BEEN A COMPLETE HALT IN VACCINATING UNTIL CLEAR AND CONCISE INSTRUCTIONS WERE MADE AVAILABLE TO THE HEALTHCARE INDUSTRY. CLEAR AND CONCISE DOES NOT MEAN SIFTING THROUGH 72 PAGES AND CLICKING ON MULTIPLE LINKS TO FIND THE NEEDLE IN THE HAYSTACK.  NOW WE HAVE A VACCINATION ERROR DUE TO THE LACK OF INFORMATION FROM THOSE IN CHARGE WHO DROPPED THE BALL. WE TAKE NO FAULT IN THIS ERROR. THIS PATIENT SHOULD HAVE RECEIVED THE BLUE CAP GRAY LABEL BIVALENT BUT RECEIVED THE YELLOW LABEL PINK TOP BIVALENT. (WHO USES THESE DESCRIPTIONS TO CLEARLY INSTRUCT PEOPLE ON WHAT TO DO?) THIS IS UNSAFE AND UNCLEAR. YOU ALSO ASSUME THAT WE HAVE KNOWLEDGE OF ALL THE VIALS AND DIFFERENT FORMULATIONS OUT THERE WHEN WE DON'T. YOU TOTALLY DROPPED THE BALL AND THIS ERROR RESTS ON THOSE WHO MAKE THE RULES AND INSTRUCTIONS.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Hypoxia
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE HYPOXIA
Age: 75.0
Sex: M
Vaccine: COVID19-2, FLUA4
Symptoms: Abdominal discomfort, Abdominal pain, Bladder scan, Blood pressure decreased, COVID-19
Clinical narrative: Discharge Provider:  Primary Care Provider: FNP Admission Date: 4/10/2023 Discharge Date: 4/14/2023   Clinical Narrative: Patient is a 76 y.o. male patient of FNP who presented 4/10/23 with traumatic wound dehiscence after falling after a recent right knee surgery.  The patient states he recently discharged home which time he was feeling quite well. He was looking forward to returning home but as he approached his home had become increasingly nauseated.  He had suffered with several bouts of vomiting.  This has not recurred and he was not quite certain as to why it happened.  He did report being severely constipated/obstipated and reports that it took a while before things began to move.  He was having abdominal cramping prior to that and improved upon having a large bowel movement.  He unfortunately reports that he fell after not feeling well.  He fell immediately after attempting to stand.  He struck his knee and suffered from wound dehiscence which required repeat surgical intervention with Dr..    During admission his blood pressure and fell requiring pressors concern for septic shock. Sepsis initially thought to be secondary to cellulitis but found to be more likely 2/2 COVID infection. He improved during his stay and was empirically treated with antibiotics. SAR was recommended; pt initially refused but reconsidered.   On day of discharge, pt mentioned feeling he is not getting full breaths of air. No CP, pleurisy or overt dyspnea. His looked comfortable, saturating 100% oxygen on room air with lungs clear and pulse in 60s. He also stated he feels like he hasn't urinated since the night before and feeling lower abdominal pressure. CXR and bladder scan were ordered. CXR was negative for any acute abnormality. PE considered but deemed unlikely on enoxaparin prophylaxis with normal heart rate and normal saturations. Bladder scan revealed 480cc pt was able to void 275 so no straight cath was indicated. Pt reported his breathing is normal after voiding.    Pt was discharged in stable condition to SAR.